CDK3/CycE2 Recombinant Human Active Protein Kinase
CDK3 is a major player driving retinoblastoma (Rb) phosphorylation during the G0/G1 transition and in the early G1 phase of the cell cycle. CDK3 interacts with various transcription factors involved in cell proliferation, differentiation, and transformation driven by the EGFR/Ras signaling pathway. CDK3/CycE2 Recombinant Human Active Protein Kinase is an ortholog of CDK3[1].
Product Specifications
UNSPSC
12352211
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
[CDK3/CycE2RecombinantHumanActiveProteinKinase]
References & Citations
[1]Teo T, et al. An overview of CDK3 in cancer: clinical significance and pharmacological implications. Pharmacol Res. 2022 Jun;180:106249.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
